Monte Rosa Therapeutics Inc
GLUE
NASDAQ
Biotechnology
$15.50
USD
-0.34 (-2.15%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $1.35B
Volume 509.2K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
ABSI | Absci Corp | $1.53B | - | -61.9% | - | |
AVBP | ArriVent BioPharma Inc | $1.44B | - | - | - | |
ORIC | Oric Pharmaceuticals Inc | $1.42B | - | - | - | |
INBX | Inhibrx Biosciences Inc | $1.37B | - | +550.0% | - | |
GLUE | Monte Rosa Therapeutics Inc | $1.35B | - | -83.9% | - | |
AKTS | Aktis Oncology Inc | $1.33B | - | +49.9% | - | |
PURR | Hyperliquid Strategies Inc | $1.32B | - | - | - | |
JBIO | Jade Biosciences Inc | $1.32B | - | - | - | |
MNKD | MannKind Corp | $1.29B | - | +30.5% | - | |
NVAX | Novavax Inc | $1.27B | - | -61.6% | - |
Top Peer by Growth
Inhibrx Biosciences Inc
+550.0% YoY Revenue
Best 1-Year Return
Inhibrx Biosciences Inc
+348.7% Return